An ACEP-developed provision that requires the Department of Defense to share controlled substance prescribing information of TRICARE beneficiaries with state prescription drug monitoring programs was successfully passed into law as part of H.R. 5515, the John S. McCain National Defense Authorization Act for Fiscal Year 2019. ACEP staff worked closely with Rep. Mike Turner (D-OH) to develop this legislative effort and ensure its inclusion in this year’s defense authorization bill.
No Responses to “ACEP-Led Provision Boosts Prescription Drug Monitoring Programs”